IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation

Cell Mol Immunol. 2015 Jan;12(1):31-9. doi: 10.1038/cmi.2014.58. Epub 2014 Aug 4.

Abstract

Plasma cells, which secrete auto-antibodies, are considered to be the arch-criminal of autoimmune diseases such as systemic lupus erythematosus, but there are many cytokines involved in inducing the differentiation of B-cell subsets into plasma cells. Here, we emphasize IL-21, which has emerged as the most potent inducer of plasma cell differentiation. In this review, we focused on the promoting effects of IL-21 on plasma cell differentiation and discuss how these effects contribute to B cell-mediated autoimmune disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autoantibodies / metabolism
  • B-Lymphocyte Subsets / immunology*
  • Cell Differentiation
  • Humans
  • Interleukins / immunology*
  • Lupus Erythematosus, Systemic / immunology*
  • Plasma Cells / immunology*

Substances

  • Autoantibodies
  • Interleukins
  • interleukin-21